Literature DB >> 12907531

The proportional Venn diagram of obstructive lung disease: two approximations from the United States and the United Kingdom.

Joan B Soriano1, Kourtney J Davis, Bobbie Coleman, George Visick, David Mannino, Neil B Pride.   

Abstract

STUDY
OBJECTIVES: The nonproportional Venn diagram of obstructive lung disease (OLD) produced for the 1995 American Thoracic Society guidelines has not been quantified. We aim to quantify the proportion of the general population with OLD and the intersections of physician-diagnosed asthma, chronic bronchitis, and emphysema in the United States and the United Kingdom, and to examine the relationship to obstructive spirometry. DESIGN AND PARTICIPANTS: We analyzed data from the US National Health and Nutrition Examination (NHANES) III survey (1988 to 1994) and the UK General Practice Research Database for the year 1998.
RESULTS: The areas of intersection among the three OLD conditions produced seven mutually exclusive disease groups. The asthma-only group was the largest proportion of OLD patients, accounting for 50.3% and 79.4% of all OLD patients in the United States and the United Kingdom, respectively, and decreased with increasing age. Overall, 17% and 19% of OLD patients in the United States and in the United Kingdom, respectively, reported more than one OLD condition, and this percentage increased with age. According to the spirometry data from NHANES III, only 37.4% of emphysema-only patients had objective airflow obstruction. The prevalence of airflow obstruction was significantly higher among participants with combinations of emphysema and chronic bronchitis (57.7%), with emphysema and asthma (51.9%), and with all three OLD diseases concomitantly (52.0%).
CONCLUSION: Concomitant diagnosis of asthma, chronic bronchitis, or emphysema is common among OLD patients from the general population, particularly in adults aged > or = 50 years.

Entities:  

Mesh:

Year:  2003        PMID: 12907531     DOI: 10.1378/chest.124.2.474

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  96 in total

1.  Association between air pollution exposure and exhaled nitric oxide in an elderly population.

Authors:  G Adamkiewicz; S Ebelt; M Syring; J Slater; F E Speizer; J Schwartz; H Suh; D R Gold
Journal:  Thorax       Date:  2004-03       Impact factor: 9.139

2.  Current situation of asthma-COPD overlap syndrome (ACOS) in Chinese patients older than 40 years with airflow limitation: rationale and design for a multicenter, cross-sectional trial (study protocol).

Authors:  Jian Kang; Wanzhen Yao; Baiqiang Cai; Ping Chen; Xia Ling; Hongyan Shang
Journal:  J Thorac Dis       Date:  2016-12       Impact factor: 2.895

Review 3.  Treating asthma in the older patient: is there a place for leukotriene modifiers?

Authors:  Mitchell H Grayson; Phillip E Korenblat
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

Review 4.  The adult asthmatic.

Authors:  Amir A Zeki; Nicholas J Kenyon; Ken Yoneda; Samuel Louie
Journal:  Clin Rev Allergy Immunol       Date:  2012-08       Impact factor: 8.667

5.  Exhaled nitric oxide predicts eosinophilic airway inflammation in COPD.

Authors:  Kun-Ta Chou; Kang-Cheng Su; Shiang-Fen Huang; Yi-Han Hsiao; Ching-Min Tseng; Vincent Yi-Fong Su; Shih-Chieh Hung; Diahn-Warng Perng
Journal:  Lung       Date:  2014-05-11       Impact factor: 2.584

Review 6.  Epidemiology of the origins of airflow limitation in asthma.

Authors:  Stefano Guerra; Fernando D Martinez
Journal:  Proc Am Thorac Soc       Date:  2009-12

Review 7.  Managing older patients with coexistent asthma and chronic obstructive pulmonary disease: diagnostic and therapeutic challenges.

Authors:  Vanessa M McDonald; Isabel Higgins; Peter G Gibson
Journal:  Drugs Aging       Date:  2013-01       Impact factor: 3.923

8.  Erratum to: Safety Considerations of Inhaled Corticosteroids in the Elderly.

Authors:  Salvatore Battaglia; Irene Cardillo; Federico Lavorini; Mario Spatafora; Nicola Scichilone
Journal:  Drugs Aging       Date:  2015-12       Impact factor: 3.923

9.  Misdiagnosis of patients receiving inhaled therapies in primary care.

Authors:  José Luis Izquierdo; Antonio Martín; Pilar de Lucas; José Miguel Rodríguez-González-Moro; Carlos Almonacid; Alexandra Paravisini
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2010-08-09

Review 10.  Use of azithromycin in the treatment of acute exacerbations of COPD.

Authors:  Aaron P Milstone
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.